PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04
Reported: March 20, 2013 Initiated: January 11, 2013 #D-199-2013
Product Description
PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04
Reason for Recall
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.
Details
- Recalling Firm
- AstraZeneca LP
- Units Affected
- 64675 cartons
- Distribution
- Nationwide
- Location
- Westborough, MA
Frequently Asked Questions
What product was recalled? ▼
PULMICORT RESPULES 0.5 mg/2 ml (30 ampules/carton) Budesonide Inhalation Suspension NDC: 0186-1989-04. Recalled by AstraZeneca LP. Units affected: 64675 cartons.
Why was this product recalled? ▼
Does Not Meet Monograph: Budesonide may be slightly above or below the specification range.
Which agency issued this recall? ▼
This recall was issued by the FDA Drug on March 20, 2013. Severity: Low. Recall number: D-199-2013.
Related Recalls
NHTSA Critical
LEXUS 2025: POWER TRAIN:AUTOMATIC TRANSMISSION
LEXUS · 2026-02-18
NHTSA Critical
CADILLAC,CHEVROLET,GMC 2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CADILLAC,CHEVROLET,GMC · 2026-02-13
NHTSA Critical
CHEVROLET,GMC 2020-2022: POWER TRAIN:AUTOMATIC TRANSMISSION:CONTROL MODULE:SOFTWARE
CHEVROLET,GMC · 2026-02-12
NHTSA Critical
CADILLAC 2024: BACK OVER PREVENTION:SOFTWARE
CADILLAC · 2026-02-12
NHTSA Critical
NISSAN 2024-2025: FUEL SYSTEM, GASOLINE:FUEL INJECTION SYSTEM:THROTTLEBODY/MANIFOLD
NISSAN · 2026-02-12